Skip to main content
. Author manuscript; available in PMC: 2014 Jan 30.
Published in final edited form as: Cancer. 2012 Jan 26;118(18):4471–4477. doi: 10.1002/cncr.27429

Table 5.

Adverse Events (Frequency ≥ 10%)

Adverse Event Grade 1-2 (%) Grade 3-4 (%)
Nausea 62 -
ALT increase 57 10
Skin rash 58 -
Bilirubin increase 52 3
Diarrhea 30 2
Vomiting 20 -
AST increase 13 3
Creatinine increase 12 2
Mucositis 12 -
Headache 12 -
Hand-foot-syndrome 7 2